Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by qwerty22on May 06, 2021 1:35pm
86 Views
Post# 33141823

RE:We are just cheerleaders now

RE:We are just cheerleaders now

1st April 2019

"“Data analysis is ongoing and Theratechnologies will quickly establish a strategy regarding the potential options now available for the continued development of tesamorelin,” said Luc Tanguay President and CEO of Theratechnologies."

https://stockhouse.com/news/press-releases/2019/04/01/study-confirms-tesamorelin-significantly-reduces-liver-fat-in-hiv-patients-with

2 years and 1 month on they still haven't got over the STARTING LINE. For all the positive things that have happened, including some very, very positive things, that's what dominates our reality. Messaging has moved as fast as the clinical program, that's to say not at all, that's really how it should be.

With the obsession with marketing and messaging people here seem to have forgotten this clinical program has stalled before it even started. The company need to prove that's not permanent. I believe they eventually will but they have to prove that.

Marketing/messaging might be a weakness that needs to be fixed but it's just not where the problems start.


jeffm34 wrote:

Since we just gave up our right to complain anymore I guess we are resigned to being cheer leaders now. 

Paul and Dawn you have done an amazing job. Don't change a thing ! There is no one else outside of Montreal that could possibly be of any help to the company. Keep up the awesome work. 



<< Previous
Bullboard Posts
Next >>